000			01968 a2200481 4500
005			20250517133709.0
264		0	_c20180222
008			201802s 0 0 eng d
022			_a1815-7920
024	7		_a10.5588/ijtld.16.0469 _2doi
040			_aNLM _beng _cNLM
100	1		_aMoro, R N
245	0	0	_aFactors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trial. _h[electronic resource]
260			_bThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _c03 2017
300			_a286-296 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAntitubercular Agents _xadministration & dosage
650	0	4	_aDirectly Observed Therapy _xmethods
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aIll-Housed Persons _xstatistics & numerical data
650	0	4	_aHumans
650	0	4	_aIsoniazid _xadministration & dosage
650	0	4	_aLatent Tuberculosis _xdrug therapy
650	0	4	_aMale
650	0	4	_aMedication Adherence
650	0	4	_aMultivariate Analysis
650	0	4	_aProportional Hazards Models
650	0	4	_aRisk Factors
650	0	4	_aSex Factors
650	0	4	_aTime Factors
700	1		_aSterling, T R
700	1		_aSaukkonen, J
700	1		_aVernon, A
700	1		_aHorsburgh, C R
700	1		_aChaisson, R E
700	1		_aHamilton, C D
700	1		_aVillarino, M E
700	1		_aGoldberg, S
773	0		_tThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease _gvol. 21 _gno. 3 _gp. 286-296
856	4	0	_uhttps://doi.org/10.5588/ijtld.16.0469 _zAvailable from publisher's website
999			_c26784770 _d26784770